✦ScienexySCIENCE KNOWLEDGE LIBRARY
General science · SCI-FORM-MED-1366

Relative Bioavailability

Relative bioavailability compares systemic drug exposure from a test formulation with exposure from a reference formulation. It accounts for differences in administered amounts and is commonly used in formulation comparison studies.

\(F_{\mathrm{rel}} = (AUC_{\mathrm{test}}/AUC_{\mathrm{reference}}) \times (Dose_{\mathrm{reference}}/Dose_{\mathrm{test}})\)

What this formula means

Relative bioavailability compares systemic drug exposure from a test formulation with exposure from a reference formulation. It accounts for differences in administered amounts and is commonly used in formulation comparison studies.

Scientific principle

Principle

Two formulations containing the same active compound can produce different systemic exposures because of differences in dissolution, absorption and formulation characteristics. Relative bioavailability quantifies their exposure ratio.

Derivation

  • Let AUC_test represent systemic exposure from the test formulation.

  • Let AUC_reference represent exposure from the reference formulation.

  • For linear pharmacokinetics, exposure is proportional to bioavailable amount.

  • Correct the exposure ratio for any difference in administered amounts.

  • Therefore, F_rel = (AUC_test/AUC_reference) × (Dose_reference/Dose_test).

  • When the administered amounts are equal, the expression simplifies to the ratio of the two AUC values.

Final Result

F_rel = (AUC_test/AUC_reference) × (Dose_reference/Dose_test).

Variables and their meanings

Frel

Relative bioavailability.

AUCtest

Area under the concentration-time curve for the test formulation.

AUCreference

Area under the concentration-time curve for the reference formulation.

Dosetest

Administered amount of the test formulation.

Dosereference

Administered amount of the reference formulation.

SI units and conversions

Frel

Dimensionless ratio or percentage.

AUC

mg·h·L⁻¹.

Dose

mg or μg.

Conditions of use

  • The test and reference formulations should contain the same active drug for a direct comparison.

  • Dose differences must be normalized.

  • The study should use comparable sampling and analytical procedures.

  • Linear pharmacokinetics are assumed for straightforward dose normalization.

  • Study design should control relevant sources of variability.

Limitations and assumptions

  • Relative bioavailability does not establish absolute bioavailability.

  • AUC comparison alone does not fully characterize absorption rate.

  • Different study conditions can influence measured exposure.

  • Nonlinear pharmacokinetics can invalidate simple dose normalization.

  • Relative bioavailability is not automatically equivalent to regulatory bioequivalence.

Step-by-step worked examples

ProblemSolutionAnswer

A test formulation produces an AUC of 60 mg·h·L⁻¹, while the reference formulation produces 50 mg·h·L⁻¹. The administered amounts are equal. Calculate relative bioavailability.

  • F_rel = (AUC_test/AUC_reference) × (Dose_reference/Dose_test).

  • The dose ratio is 1.

  • F_rel = 60/50.

  • F_rel = 1.20.

  • Percentage relative bioavailability = 120%.

Relative bioavailability is 120%.

A test formulation has an AUC of 36 mg·h·L⁻¹ and a modeled administered amount of 150 mg. A reference formulation has an AUC of 40 mg·h·L⁻¹ and an administered amount of 100 mg. Calculate relative bioavailability.

  • F_rel = (AUC_test/AUC_reference) × (Dose_reference/Dose_test).

  • F_rel = (36/40) × (100/150).

  • F_rel = 0.90 × 0.6667.

  • F_rel ≈ 0.60.

  • Percentage relative bioavailability ≈ 60%.

Relative bioavailability is approximately 60%.

Real-world applications

  • Comparing pharmaceutical formulations.

  • Studying generic and reference products.

  • Evaluating formulation changes.

  • Analyzing drug absorption differences.

  • Supporting pharmaceutical development research.

Formula Meaning

Relative bioavailability compares systemic drug exposure from a test formulation with exposure from a reference formulation. It accounts for differences in administered amounts and is commonly used in formulation comparison studies.

Sources and further reading

No source has been supplied for this item yet. Treat the claim as needing editorial verification.

← Back to Formula Hub · Suggest a correction or source